Main content
Sorry, this episode is not currently available

A Risk Worth Taking?

Shelley Jofre investigates the drug Avandia and asks whether the medicine's regulator is putting the interests of the drugs industry before patients.

We're in the grip of a diabetes epidemic. The NHS spent more than half a billion pounds on medication for it in 2009. Patients trust that these drugs are safe, but does one come with a hidden cost to health? Shelley Jofre investigates the rise and fall of Avandia, until recently one of the UK's best-selling diabetes drugs, and asks whether the medicine's regulator is putting the interests of the drugs industry before patients.

29 minutes

Credits

Role Contributor
Presenter Jeremy Vine
Producer Angie Mason
Reporter Shelley Jofre

Broadcasts